Made Scientific and Streamline Bio Launch Early Adopter Program for AI-Driven Cell Therapy Automation
Made Scientific becomes the exclusive CDMO partner for Streamline Bio's AI-driven robotic manufacturing platform, aiming to enhance cell therapy production. The partnership focuses on automating workflows in GMP environments and optimizing CAR-T manufacturing processes.
Theia Market Signal Identification - AI Assisted
Made Scientific has been designated as the exclusive contract development and manufacturing organization (CDMO) partner for Streamline Bio's AI-driven robotic manufacturing platform. This partnership aims to accelerate the development of automated workflows in GMP cleanroom environments.
The program will focus on integrating and validating Streamline Bio's technology, targeting improvements in cycle-time optimization and operational scalability for CAR-T manufacturing. The collaboration seeks to provide scalable, cost-effective manufacturing solutions for cell therapies.
Comments